Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna(®) Test in the management of early-stage breast cancers

PURPOSE: The Prosigna(®) breast cancer prognostic gene signature assay identifies a gene-expression profile that permits the classification of tumors into subtypes and gives a score for the risk of recurrence (ROR) at 10 years. The primary objective of this multicenter study was to evaluate the impa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Hequet, Delphine, Callens, Céline, Gentien, David, Albaud, Benoit, Mouret-Reynier, Marie-Ange, Dubot, Coraline, Cottu, Paul, Huchon, Cyrille, Zilberman, Sonia, Berseneff, Helene, Foa, Cyril, Salmon, Rémy, Roulot, Aurélie, Lerebours, Florence, Salomon, Anne, Ghali, Nadeem, Morel, Pascale, Li, Qianyi, Cayre, Anne, Guinebretière, Jean-Marc, Hornberger, John, Penault-Llorca, Frédérique, Rouzier, Roman
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5646764/
https://ncbi.nlm.nih.gov/pubmed/29045452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0185753
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados